Novartis AG (NYSE:NVS) is set to post its quarterly earnings results before the market opens on Tuesday, October 24th. Analysts expect Novartis AG to post earnings of $1.25 per share for the quarter.

Shares of Novartis AG (NYSE NVS) opened at 85.74 on Friday. The stock has a market capitalization of $200.88 billion, a P/E ratio of 31.30 and a beta of 0.73. The company has a 50 day moving average price of $85.60 and a 200-day moving average price of $82.21. Novartis AG has a 1-year low of $66.93 and a 1-year high of $86.90.

TRADEMARK VIOLATION NOTICE: “Novartis AG (NVS) Scheduled to Post Earnings on Tuesday” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece can be read at

A number of equities analysts recently issued reports on the company. Zacks Investment Research raised Novartis AG from a “hold” rating to a “buy” rating and set a $96.00 price objective for the company in a report on Tuesday, September 19th. Morgan Stanley raised Novartis AG from an “underweight” rating to an “overweight” rating in a report on Wednesday, July 26th. Credit Suisse Group lowered Novartis AG from a “neutral” rating to an “underperform” rating and set a $82.25 price objective for the company. in a report on Wednesday, July 5th. Cowen and Company set a $77.00 price objective on Novartis AG and gave the stock a “hold” rating in a report on Tuesday, July 11th. Finally, BidaskClub raised Novartis AG from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the company’s stock. Novartis AG presently has a consensus rating of “Hold” and a consensus price target of $84.13.

Novartis AG Company Profile

Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. The Company’s segments include Innovative Medicines, Sandoz, Alcon and Corporate activities.

Earnings History for Novartis AG (NYSE:NVS)

Receive News & Stock Ratings for Novartis AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novartis AG and related stocks with our FREE daily email newsletter.